New York-based biotech giant Regeneron Pharmaceuticals announced May 19 its plan to purchase the bankrupt genetic testing firm 23andMe in a $256 million deal that could include millions of Americans' ...

On Monday, Regeneron Pharmaceuticals announced that it would acquire most of 23andMe's assets for $256 million. According to ...

Amazon Prime Day isn't over just yet: The online retail giant is still dishing out deals on thousands of its best-selling products. Just when you thought you were all shopped out, Amazon rolls out ...

Following a 2023 data breach and a bankruptcy and sale process in 2025, the genetic testing company 23andMe will pay $6 ...

The top bidder in the DNA testing firm's bankruptcy auction, Regeneron vows to prioritize the privacy, security, and ethical use of customer data. Following a data breach and bankruptcy, genetic ...

If you want to learn a bit more about your genetic makeup, there’s no shortage of companies offering to rifle through your DNA. 23andMe is among the very best known, having had past investment from ...

Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction, the companies said Monday. Regeneron said it will comply with 23andMe’s privacy ...

DNA tests are being framed as a fun ancestry project in the past few years, but for anyone who remembers the days of Maury Povich better than 23andMe ancestry TikTok unboxings knows they can be a ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. This year, skip the clutter and gift pure ...

Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals’ offer for the DNA-testing company in a bankruptcy auction.